[Federal Register Volume 78, Number 37 (Monday, February 25, 2013)]
[Notices]
[Page 12825]
[FR Doc No: 2013-04290]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket No. FRA-1999-5102]

Petition for Extension of Waiver of Compliance

    In accordance with Part 211 of Title 49 Code of Federal Regulations
(CFR), this document provides the public notice that by a document
dated February 1, 2012, the Southeastern Pennsylvania Transportation
Authority (SEPTA) has petitioned the Federal Railroad Administration
(FRA) for an extension of a waiver of compliance from certain
provisions of the Federal railroad safety regulations contained at 49
CFR part 213, Track Safety Standards. The docket number associated with
this petition is FRA-1999-5102.
    Specifically, SEPTA seeks to extend a waiver from 49 CFR
213.233(c), relating to the frequency of the required visual track
inspections. FRA issued the initial waiver that granted SEPTA relief on
July 24, 2000, and FRA extended the waiver on August 4, 2003, and
February 28, 2008.
    SEPTA requests an extension of approval to reduce the frequency of
required, visual track inspections for certain tracks that carry
passenger traffic, specifically only those tracks that are constructed
with continuous welded rail. SEPTA proposes to conduct one visual track
inspection per week, instead of the two inspections per week that are
required in 49 CFR part 213, and to supplement its visual inspections
with the operation of an automated track geometry measuring vehicle
over the affected main tracks and sidings four times per year. SEPTA
has owned and operated such a measuring vehicle since 1990.
    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov and in person at the U.S. Department of
Transportation's Docket Operations Facility, 1200 New Jersey Ave. SE.,
W12-140, Washington, DC 20590. The Docket Operations Facility is open
from 9 a.m. to 5 p.m., Monday through Friday, except Federal Holidays.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested parties
desire an opportunity for oral comments, they should notify FRA in
writing before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be submitted by any of the following
methods:
     Web site: http://www.regulations.gov/. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except for Federal Holidays.
    Communications received by April 11, 2013 will be considered by FRA
before final action is taken. Comments received after that date will be
considered as far as practicable.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the comment (or signing the document,
if submitted on behalf of an association, business, labor union, etc.).
See http://www.regulations.gov/#!privacyNotice for the privacy notice
of regulations.gov or interested parties may review DOT's complete
Privacy Act Statement in the Federal Register published on April 11,
2000 (65 FR 19477).

    Issued in Washington, DC, on February 20, 2013.
Robert C. Lauby,
Deputy Associate Administrator for Regulatory and Legislative
Operations.
[FR Doc. 2013-04290 Filed 2-22-13; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register: December 29, 2009 (Volume 74, Number 248)]
[Notices]
[Page 68912-68913]
[DOCID:fr29de09-155]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Second Meeting, Special Committee 223: Airport Surface Wireless
Communications

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of RTCA Special Committee 223: Airport Surface Wireless
Communications meeting.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a
meeting of RTCA Special Committee 223: Airport Surface Wireless
Communications.

DATES: The meeting will be held January 26-27, 2010 from 9 a.m.-5 p.m.

ADDRESSES: The meeting will be held at RTCA, Inc., 1828 L Street, NW.,
Suite 805, Washington, DC 20036.

FOR FURTHER INFORMATION CONTACT: RTCA Secretariat, 1828 L Street, NW,
Suite 805, Washington, DC 20036; telephone<PHONE_NUMBER>; fax (202)
833-9434; Web site http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., Appendix 2), notice
is hereby given for a RTCA Special Committee 223: Airport Surface
Wireless Communications meeting. The agenda will include:

Tuesday, January 26, 2010

Tuesday Morning--Plenary:

     Opening Session (Welcome, Introductions, Administrative
Remarks, Approve/Review Meeting 1 Summary).
     Special Committee Leadership.
     Designated Federal Official (DFO): Mr. Brent Phillips.
     Co-Chair: Mr. Aloke Roy, Honeywell International.
     Co-Chair: Mr. Ward Hall, ITT Corporation.
     Agenda Overview.
     Report from EUROCAE WG 82 Kick-off meeting.
     AeroMACS Profile Working Group Status.

Tuesday Afternoon--Profiles WG Breakout Session:

     Document Structure.
     Review of AeroMACS System Requirements Document from
EUROCONTROL.
     Technical work on AeroMACS Profile.

Wednesday, January 27, 2010

Wednesday Morning--Profiles WG Breakout Session:

     Continue AeroMACS Profile definition.

Wednesday Afternoon--Reconvene Plenary:

     Profiles WG Status Report and Plenary Guidance.
     Establish Agenda, Date and Place for the next plenary
meeting.
     Review of Meeting summary report.
     Adjourn--Expected by 3 p.m. on January 27.
    Attendance is open to the interested public but limited to space
availability. With the approval of the chairmen, members of the public
may present oral statements at the meeting. Persons wishing to present
statements or obtain information should contact the person listed in
the FOR FURTHER INFORMATION CONTACT section. Members of the public may
present a written statement to the committee at any time.

    Issued in Washington, DC, on December 22, 2009.
Francisco Estrada C.,
RTCA Advisory Committee.
[FR Doc. E9-30778 Filed 12-28-09; 8:45 am]

BILLING CODE 4910-13-P


1 August 31, 2005 MEMORANDUM Subject: Response to Public Comments on the Draft Risk Assessment for 1,2 Benzisothiazolin 3 one ( BIT).

From: Rebecca Miller, Chemical Review Manager Antimicrobials Division Office of Pesticide Programs To: OPP Public Docket for 1,2 Benzisothiazolin 3 one ( BIT) Docket # OPP 2005 0200 Introduction This document addresses the public comments. The public comments were based solely on those submitted on behalf of Acti Chem Specialties, Inc.; Arch Chemicals, Inc., Clariant Corporation; International Specialty Products, Rohm & Haas Company, and Troy Corporation in response to EPA's draft risk assessment ( RA) for BIT. The comments submitted by these registrants include areas of toxicology, exposure, and risks. EPA has responded to the specific comments, and where appropriate, has made modifications to the RA as noted below.

RA Incorporated Comments The following captures the changes the Agency has made to the draft risk assessment based on the public comments received in Phase 3 of the Tolerance Reassessment Advisory Committee ( TRAC) process.

° Additional risk characterization language will be added to account for the 100% bioavailability factor assumed for the occupational airless sprayer handler MOE. The characterization is qualitative indicating that EPA believes that the paint matrix will most likely reduce the dermal absorption of BIT, and therefore, the dermal MOE of 90 may be an overestimate of risk.

° The need for additional carcinogenicity data for the metal working fluid ( MWF) use of BIT will only be held in reserve if the use is restricted to " enclosed metal working systems". Otherwise, the carcinogenicity data are still required.

° A second application rate will be added to the PRA for the pet product use ( i. e., 0.032 percent ai).

° The textile use will be properly characterized to reflect the low adsorption of BIT to clothing and the fact that the estimate does not include the reduction in the 2 amount of BIT within the washer after the spin cycle. This new information will preclude the need for confirmatory data.

° Additional risk characterization language will be added to the handler risk assessment for oil recovery fluids to better characterize the potential extrapolation error for large volumes. The inhalation MOEs presented for all of the other scenarios are greater then 1000, and therefore, a confirmatory inhalation toxicity study is not warranted.

General Comments and Responses The comments are summarized as presented by the registrants.

( 1) Comment: Use Closure Memorandum of Agreement: On June 30, 2003, EPA held a SMART meeting on BIT. This meeting was attended by representatives of several of the above BIT registrants. EPA issued SMART meeting minutes via its cover memo dated September 12, 2003 ( copy being submitted herewith). EPA requested that registrants provide comments on the minutes and indicated that a final Use Closure Memorandum of Agreement would be provided to the registrants. Several registrants, in our 30 day comments on the first draft BIT RED, commented that EPA had not issued the Use Closure Memorandum of Agreement. To date, none of the BIT registrations, to our knowledge, has received a Use Closure Memorandum of Agreement for BIT. Nevertheless, BIT's use has been reviewed in several draft versions of the BIT RED document and we can agree that BIT's use patterns can be categorized to include the following generic use patterns: material preservatives ( indoor food use [ that is, indirect food additive use] and indoor/ outdoor non food); industrial processes ( indoor non food), and indoor and outdoor residential uses.

EPA Response: A Use Closure Memorandum was not issued for BIT, however, the use patterns are in agreement between the registrants and EPA.

( 2) Comment: Dermal Toxicity Endpoint Selection: For reasons explained in our letter dated July 5, 2005, we believe that EPA should be using the calculated dermal NOAEL of 123 mg/ kg/ day based on the actual 90 day rat dermal toxicity study and the BIT dermal absorption study rather than an oral NOAEL of 5 mg/ kg/ day from the 90 day oral dog study when conducting dermal exposure assessments.

EPA Response: EPA considered the entire data base that was available for BIT in selecting endpoints. When new data were presented, the Antimicrobial's Division Toxicology Endpoint Selection Committee ( ADTC) re evaluated the endpoints, taking into consideration the impact that any new data would have on previous decisions. In carrying out the task of endpoint selection, the subchronic dermal toxicity study in rats was evaluated for its utility in the establishment of a dermal endpoint.

The 90 day dermal toxicity study was determined by the committee to have flaws that confounded its usefulness in the endpoint selection process. It appeared from the results 3 of this study, that the rats were not only exposed dermally to BIT but that there was a degree of oral exposure, possibly from ingestion of the test substance, that resulted in gastric irritation at all dose levels. Dermal irritation was also reported at all dose levels and a NOAEL could not be determined with a high level of confidence. It was not clear to the committee, based on these findings, what the actual dermal dose would have been for those treated animals.

With regard to the use of the subchronic dog study in setting endpoints, this study was supported by findings in the subchronic rat study in which the NOAEL was approximately 8 mg/ kg/ day compared to a NOAEL of 5 mg/ kg/ day in the dog study. Although the observations were somewhat different for the two different species, the NOAELs are within the same general range.

( 3) Comment: Carcinogenicity Data Requirements for the use of BIT as a Preservative for Metal Working Fluids: We wish to reiterate comments made in our July 5, 2005 letter, that is, in light of favorable MOE's and EPA's lack of concern regarding the use of BIT as a MWF preservative, the available toxicity data base for the isothiazolin class of biocides does not warrant any additional carcinogenicity data on BIT, or any other isothiazolin biocide.

EPA Response: The Agency has read the registrant's comment regarding the need for carcinogenicity data on BIT with respect to metalworking fluid use, and has the following responses:

a) Carcinogenicity risk assessment is separate from non cancer risk assessment. Margins of Exposure are not typically involved in a carcinogenicity risk assessment except in cases where there is clear demonstration of noncarcinogenicity or the mode of action framework as presented in the Agency's Guidelines for Carcinogen Risk Assessment is followed and it is demonstrated that the chemical in question causes cancer through a non linear mode of action.

b) In the case of BIT, there is no carcinogenicity data for the chemical. The registrant cites a chronic drinking water study in rats that was conducted on a mixture of two isothiazolin chemicals, 5 chloro 2 methyl 4 isothiazolin3 one ( CMIT) and 2 methyl 4 isothiazolin 3 one ( MIT) in which no increase in tumors was observed. The mixture tested was 14.2% a. i. The Health Effects Division's RfD Peer Review Committee in 1995 assigned a Group " D" classification for this chemical mixture based on the absence of a study in a second species and the corrosive nature of the material which limited doses that could be administered.

c) The CMIT/ MIT chemical tested in the chronic toxicity study ( MRID 43140701) was a 14.2% a. i. BIT is reported in submitted toxicity studies as 73 100% a. i. Further, the chemical structure of BIT is not felt to be so closely related to CMIT/ MIT that an argument can be made to bridge data for CMIT/ MIT to BIT. 4 d) The registrant may claim that a carcinogenicity study would not be required for the metalworking fluid use if the use is for " enclosed metalworking systems". Under this scenario, it has been determined that certain toxicology data requirements including carcinogenicity testing would be held in reserve pending review of worker exposure in such enclosed systems ( July 5, 2005 memorandum from Norm Cook, Chief, Risk Assessment and Science Support Branch, Antimicrobials Division to Marshall Swindell, PM 33, Regulatory Management Branch I, Antimicrobials Division).

( 4) Comment: Commercial Airless Sprayer ( Painting): Again, we wish to reiterate comments made in our July 5, 2005 letter regarding the use of the calculated dermal tox endpoint based on the 90 day dermal study and dermal absorption study rather than on a oral tox endpoint from the oral dog study. Also, we reemphasize the fact that there is a bioavailability factor in this exposure scenario which was also discussed in our July 5, 2005 letter.

EPA Response: See the response to # 2 concerning the dermal toxicity endpoint.

In the July 5, 2005 letter, an argument was made to use a 10 percent bioavailability factor in the commercial airless paint sprayer exposure scenario. Historically, EPA/ OPP has not used a bioavailability factor for paint without chemical specific data. Nonetheless, EPA also believes that such a factor, if data were available, would indicate a reduction in the dermal absorption. EPA will add additional risk characterization language to the RA qualitatively indicating the potential reduction in the bioavailability of BIT when used in paints. The dermal risk for the exposure scenario in question ( i. e., occupational airless sprayer) is a MOE of 90 with a target MOE of 100.

( 5) Comment: Leave On Flea and Tick Aerosol Pet Products   BIT as a Preservative: We wish to reiterate comments made in our letters of July 5, 2005 and July 6, 2005 on the use of the calculated dermal NOAEL, and specifically on the use of the calculated dermal NOAEL when risk assessing the use of BIT as a preservative in leave on flea and tick aerosol pet products. By using the calculated dermal NOAEL as the tox endpoint, acceptable MOE's can be calculated.

Alternatively, it is our understanding that the leave on flea and tick aerosol pet product formulators do not use more than 320 ppm or 0.032% BIT, on an active ingredient basis, to preserve such products. In light of this, we believe that MOE's based on this maximum amount of BIT well be acceptable. Further explanation follows:

If, as a worst case scenario, the aerosol flea and tick product exposure were included in the aggregate risk assessment, the other ( Child dermal) exposures would need to be included ( see table 20 for short term exposures).

Clothing 0.0007 mg/ kg/ day mop 0.00055 mg/ kg/ day combined = 0.00125 mg BIT/ kg/ day 5 Maximum amount ( exposure) of BIT to give an MOE of 100 = 0.05 mg/ kg/ day.

Therefore, the permissible amount from aerosol flea/ tick pet products = 0.05   0.00125 = 0.04875 mg BIT/ kg/ day.

If we simply pro rata this from the data in Table 16 ( 1000 ppm BIT = 0.15 mg BIT/ kg/ day), then 320 ppm BIT in flea/ tick aerosol pet formulations = 0.048 mg BIT/ kg/ day.

Therefore this should be the maximum acceptable for aggregate risk assessment.

EPA Response: See the response to # 2 concerning the dermal toxicity endpoint.

Although the above comment refers to BIT as " an active ingredient basis, to preserve such products", the use is actually registered as an inert use. The inert percent formulation of 0.1 percent was used in all of the EPA model simulations. This value was based on the tolerance exemption limitation as specified in 40 CFR 180.920 and a review of several Confidential Statement of Formula ( CSFs) for various types of products. The registrant's willingness to reduce the percent formulation to 0.032 percent as a risk mitigation measure will provide an adequate MOE. The use of this aerosol pet product is assumed by EPA to be used on an intermittent basis and the probability of this use cooccurring with the scenarios selected for aggregation ( see Table 19 of the PRA for aggregate exposure) would be minimal, and therefore, the pet product is not included in the aggregate assessment.

( 6) Comment: Fabric Product Preservative ( BIT Used to Preserve Detergents, Fabric Softeners, Stain Removers): The element that EPA has omitted is the fact that the total active ingredient is diluted in the volume of wash water. Only the residual volume of water on the fabric ( after draining/ spinning or rinsing) will then deposit BIT onto the textile. It is only 1% of this deposited amount which is then transferred from cloth to skin.

In the equations published by HERA, EPA seems to have confused the term F1 with F'. See page 18, Human Exposure Assessment.

EPA version = Dermal Exposure ( mg/ kg/ day) = [(( M x F1 x FD)/ WI) x Sder x F2 x F3 x F4]/ BW Correct version ( see HERA web document p 70 & 71) Dermal Exposure ( mg/ kg/ day) = ( F1 x C' x Sder x n x F2 x F3 x F4)/ BW Where C' = ( M x F' x FD)/ Wl F' = percentage weight fraction of substance deposited F' = Sw/ Tw Where Sw = water mass left after spin cycle or rinse, in kg Tw = total water mass initially present, in kg. 6 Equivalent equation in EPA approach should be: Dermal Exposure ( mg/ kg/ day) = [( F1 x ( M x F' x FD)/ WI) x Sder x F2 x F3 x F4]/ BW This will significantly increase the MOE for the potential exposure based on the factor: Existing EPA MOE x Tw/ Sw BIT substantivity BIT will not adsorb onto textiles/ fabric. Washing is normally carried out at high pH, around 10, rinsing is usually pH 7 and softening at the end of the wash may be slightly acidic, pH 6   7. Under all these pH conditions, BIT will not have a positive charge. All of the common fibers used for clothing have either a negative charge, or are not charged.

Cotton, viscose, linen, acrylic   all have negative charges Nylon, polyester   no charge These fibers will have no ionic attraction for BIT. There will not be any significant hydrogen bonding and BIT does not have the extended planar aromatic structure required by dyestuffs for substantivity to cotton ( usually 3 or more aromatic rings) thus BIT will not be able to " dye" the anionic or neutral fibers. Under laundry conditions, BIT will not adsorb onto any of these fibres. The same concept applies to dyed fibers, even softened fibers   the softener is cationic, but they do not give the fiber a positive charge, just less of a negative charge.

From the above, BIT remains in the wash water and the vast majority is discharged to drain after draining/ spinning. Only a small amount of BIT will be present in the residual entrained wash water and this will be readily removed in any rinse cycle which is omitted from the above scenario. Since all textile washing incorporates some element of rinsing, it is likely that the potential for deposited residues of BIT on textiles is very low. Consequently the fraction of this residue subsequently transferred to the actual skin surface will be very low.

EPA Response: The amount of BIT remaining on the clothing after draining/ spinning/ rinsing during a wash cycle was not included in EPA's calculations. It is appropriate to include a fraction to account for the water mass left after the spin cycle divided by the total water mass initially present in washer. However, this fraction is not available at this time. As a screening level assessment, assuming a fraction of " 1" for this input still provides the regulatory managers with sufficiently high MOEs ( i. e., MOEs are in the 1000s) to make a regulatory decision. Additional characterization language will be added to the RA to capture this overestimation. In addition, the chemistry discussion concerning the lack of BIT adsorbing to fabric will be added to the RA. Initially, the RA indicated the need for the registrant to provide data to confirm the 1 percent transfer from clothing to skin cited from the HERC document. In light of the chemistry, the default of no reduction factor for draining/ spinning, and high MOEs in the screening level assessment, data to confirm the percent transfer are no longer needed. 7 ( 7) Comment: 28 Day Inhalation Study: Regarding the occupational inhalation exposure for liquid pour ( Oil recovery fluids, etc.), the MOE given in Table 5 Human Exposure Assessment is 850. An MOE > 1000 is required to obviate the need for inhalation tox studies.

The calculated MOE of 850 is artificially low due to non viable extrapolation on usage figures. The inhalation exposure is the lowest listed at 0.000403 mg / lb active ingredient. This reflects low probability of inhalation during normal scale pump addition activities. This has been directly multiplied by the usage figure of 420,000 gallon / day water. This is an abnormally large volume and is unique to the oil recovery application. At the dosage level of 300 ppm active ingredient = 1050 lb active ingredient or 5,250 lb formulated product.

At this level of usage the system has to be automated or enclosed. The only potential source of exposure would be during coupling and uncoupling of large scale dosing vessels, e. g., intermediate bulk containers, or bulk tote containers. It is unrealistic to extrapolate directly from such large volume usage to an inhalation exposure. A more realistic figure would be generated from an assessment of the number of coupling operations per shift rather than the total volume of processed liquid. Alternatively the time spent per day in ( un) coupling could be assessed.

In light of the above and the fact that all inhalation MOE's are acceptable, we believe that a 28 day inhalation study with BIT is not necessary.

EPA Response: The limitation in extrapolating the CMA exposure data for closed loading to large volumes handled is also a concern of EPA in overestimating potential exposure. The limitation in the existing CMA data for closed loading are being rectified by the ACC Biocides Exposure Task Force ( i. e., Task Force is collecting new exposure data). Based on the fact that all of the other BIT inhalation exposure scenarios indicate MOEs greater than 1000, and the estimated inhalation MOE of 830 for the liquid pump oil recovery fluids is believed to be an overestimate of exposure, a confirmatory 28 day inhalation study is not warranted at this time.


[Federal Register Volume 88, Number 66 (Thursday, April 6, 2023)]
[Notices]
[Pages 20604-20605]
[FR Doc No: 2023-07226]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Advanced Aviation Advisory Committee (AAAC); Notice of Public
Meeting

AGENCY: Federal Aviation Administration, Department of Transportation.

ACTION: Notice of Advanced Aviation Advisory Committee (AAAC) meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the AAAC.

DATES: The meeting will be held on April 26, 2023, between the hours of
1:30 p.m. and 5:00 p.m. Eastern Time.
    Requests for accommodations for a disability must be received by
April 19, 2023. Requests to submit written materials to be reviewed
during the meeting must be received no later than April 19, 2023.

ADDRESSES: The meeting will be held at the FAA Headquarters, 800
Independence Avenue SW, Washington DC 20591. In-person attendance is
limited to Advanced Aviation Advisory Committee members and selected
FAA support staff. Members of the public who wish to observe the
meeting through virtual means can access the livestream on the
following FAA social media platforms on the day of the event, https://www.facebook.com/FAA or https://www.youtube.com/FAAnews. For copies of
meeting minutes along with all other information please visit the AAAC
internet website at https://www.faa.gov/uas/programs_partnerships/advanced_aviation_advisory_committee/.

FOR FURTHER INFORMATION CONTACT: Gary Kolb, Advanced Aviation Advisory
Committee Manager, Federal Aviation Administration, U.S. Department of
Transportation, at [email protected] or<PHONE_NUMBER>. Any committee
related request or reasonable accommodation request should be sent to
the person listed in this section.

SUPPLEMENTAL INFORMATION:

I. Background

    The AAAC was created under the Federal Advisory Committee Act
(FACA), in accordance with title 5 of the United States Code (5 U.S.C.
app. 2) to provide the FAA with advice on key drone and advanced air
mobility (AAM) integration issues by helping to identify challenges and
prioritize improvements.

II. Agenda

    At the meeting, the agenda will cover the following topics:

 Official Statement of the Designated Federal Officer
 Approval of the Agenda and Minutes
 Opening Remarks
 FAA Update
 Industry-Led Technical Topics
 New Business/Agenda Topics
 Closing Remarks
 Adjourn

    Additional details will be posted on the AAAC internet website
address listed in the ADDRESSES section at least 5 days in advance of
the meeting.

III. Public Participation

    The meeting will be open to the public via a livestream. Members of
the public who wish to observe the virtual meeting can access the
livestream on the following FAA social media platforms on the day of
the event, https://www.facebook.com/FAA or https://www.youtube.com/FAAnews. The U.S. Department of Transportation is committed to
providing equal access to this meeting for all participants. If you
need alternative formats or services because of a disability, such as
sign language, interpretation, or other ancillary aids, please contact
the person listed in the FOR FURTHER INFORMATION CONTACT section.
    The FAA is not accepting oral presentations at this meeting due to
time constraints. Written statements submitted by the deadline will be
provided to the AAAC members before the meeting. Any member of the
public may submit a written statement to the committee at any time.

    Issued in Washington, DC.
Jeffrey U. Vincent,
Executive Director, UAS Integration Office, Federal Aviation
Administration.
[FR Doc. 2023-07226 Filed 4-5-23; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 84, Number 244 (Thursday, December 19, 2019)]
[Proposed Rules]
[Pages 69662-69664]
[FR Doc No: 2019-27318]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2019-0985; Product Identifier 2019-NM-183-AD]
RIN 2120-AA64

Airworthiness Directives; ATR-GIE Avions de Transport
R[eacute]gional Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: The FAA proposes to adopt a new airworthiness directive (AD)
for certain ATR-GIE Avions de Transport R[eacute]gional Model ATR42-500
airplanes. This proposed AD was prompted by a report of interference
between bonding braid screws and pitch tab control rods on the ATR
final assembly line. This proposed AD would require an inspection of
the bonding braid screws for proper installation, a detailed inspection
for damage to the pitch tab control rods if necessary, and replacement
of the pitch tab control rods if necessary, as specified in a European
Union Aviation Safety Agency (EASA) AD, which will be incorporated by
reference. The FAA is proposing this AD to address the unsafe condition
on these products.

DATES: The FAA must receive comments on this proposed AD by February 3,
2020.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE, Washington, DC 20590.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    For the material identified in this proposed AD that will be
incorporated by reference (IBR), contact the EASA, Konrad-Adenauer-Ufer
3, 50668 Cologne, Germany; telephone +49 221 89990 1000; email
<EMAIL_ADDRESS>internet www.easa.europa.eu. You may find this IBR
material on the EASA website at https://ad.easa.europa.eu. You may view
this IBR material at the FAA, Transport Standards Branch, 2200 South
216th St., Des Moines, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>. It is also available in the AD
docket on the internet at https://www.regulations.gov by searching for
and locating Docket No. FAA-2019-0985.

Examining the AD Docket

    You may examine the AD docket on the internet at https://www.regulations.gov by searching for and locating Docket No. FAA-2019-
0985; or in person at Docket Operations between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays. The AD docket contains
this NPRM, the regulatory evaluation, any comments received, and other
information. The street address for Docket Operations is listed above.
Comments will be available in the AD docket shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Shahram Daneshmandi, Aerospace
Engineer, International Section, Transport Standards Branch, FAA, 2200
South 216th St., Des Moines, WA 98198; telephone and fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    The FAA invites you to send any written relevant data, views, or
arguments about this proposal. Send your comments to an address listed
under the ADDRESSES section. Include ``Docket No. FAA-2019-0985;
Product Identifier 2019-NM-183-AD'' at the beginning of your comments.
The FAA specifically invites comments on the overall regulatory,
economic, environmental, and energy aspects of this NPRM. The FAA will
consider all comments received by the closing date and may amend this
NPRM based on those comments.
    The FAA will post all comments, without change, to https://www.regulations.gov, including any personal information you provide.
The FAA will also post a report summarizing each substantive verbal
contact the agency receives about this NPRM.

Discussion

    The EASA, which is the Technical Agent for the Member States of the
European Union, has issued EASA AD 2019-0262, dated October 22, 2019
(``EASA AD 2019-0262'') (also referred to as the Mandatory Continuing
Airworthiness Information, or ``the MCAI''), to correct an unsafe
condition for certain ATR-GIE Avions de Transport R[eacute]gional Model
ATR42-500 airplanes.
    This proposed AD was prompted by a report of interference between
bonding braid screws and pitch tab control rods on the ATR final
assembly line. The FAA is proposing this AD to address interference
between bonding braid screws and pitch tab control rods, which could
lead to failure of the rods and tab disconnection, possibly resulting
in reduced control of the airplane. See the MCAI for additional
background information.

Related IBR Material Under 1 CFR Part 51

    EASA AD 2019-0262 describes procedures for inspecting the bonding
braid screws for proper installation, doing a detailed inspection for
damage of the pitch tab control rods, and replacing the pitch tab
control rods.
    This material is reasonably available because the interested
parties have access to it through their normal course of business or by
the means identified in the ADDRESSES section.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to the FAA's bilateral agreement with the State of Design Authority,
the FAA has been notified of the unsafe condition described in the MCAI
referenced above. The FAA is proposing this AD because the FAA
evaluated all the relevant information and determined the unsafe
condition described previously is likely to exist or develop in other
products of the same type design.

Proposed AD Requirements

    This proposed AD would require accomplishing the actions specified
in EASA AD 2019-0262 described previously, as incorporated by
reference, except for any differences identified as exceptions in the
regulatory text of this AD.

Explanation of Required Compliance Information

    In the FAA's ongoing efforts to improve the efficiency of the AD
process, the FAA initially worked with Airbus and EASA to develop a
process to use certain EASA ADs as the primary source of information
for compliance with requirements for corresponding FAA ADs. The FAA has
since coordinated with other manufacturers and civil aviation
authorities (CAAs) to use this process. As a result, EASA AD

2019-0262 will be incorporated by reference in the FAA final rule. This
proposed AD would, therefore, require compliance with EASA AD 2019-0262
in its entirety, through that incorporation, except for any differences
identified as exceptions in the regulatory text of this proposed AD.
Using common terms that are the same as the heading of a particular
section in the EASA AD does not mean that operators need comply only
with that section. For example, where the AD requirement refers to
``all required actions and compliance times,'' compliance with this AD
requirement is not limited to the section titled ``Required Action(s)
and Compliance Time(s)'' in the EASA AD. Service information specified
in EASA AD 2019-0262 that is required for compliance with EASA AD 2019-
0262 will be available on the internet at https://www.regulations.gov
by searching for and locating Docket No. FAA-2019-0985 after the FAA
final rule is published.

Costs of Compliance

    The FAA estimates that this proposed AD affects 3 airplanes of U.S.
registry. The FAA estimates the following costs to comply with this
proposed AD:

                                      Estimated Costs for Required Actions
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per       Cost on U.S.
                          Labor cost                              Parts cost        product         operators
----------------------------------------------------------------------------------------------------------------
1 work-hour x $85 per hour = $85.............................              $0              $85             $255
----------------------------------------------------------------------------------------------------------------

    The FAA estimates the following costs to do any necessary on-
condition actions that would be required based on the results of any
required actions. The FAA has no way of determining the number of
aircraft that might need these on-condition actions:

                 Estimated Costs of On-Condition Actions
------------------------------------------------------------------------
                                                             Cost per
              Labor cost                   Parts cost        product
------------------------------------------------------------------------
1 work-hour x $85 per hour = $85......         $11,940          $12,025
------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.
    This proposed AD is issued in accordance with authority delegated
by the Executive Director, Aircraft Certification Service, as
authorized by FAA Order 8000.51C. In accordance with that order,
issuance of ADs is normally a function of the Compliance and
Airworthiness Division, but during this transition period, the
Executive Director has delegated the authority to issue ADs applicable
to transport category airplanes and associated appliances to the
Director of the System Oversight Division.

Regulatory Findings

    The FAA determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

ATR-GIE Avions de Transport R[eacute]gional: Docket No. FAA-2019-
0985; Product Identifier 2019-NM-183-AD.

(a) Comments Due Date

    The FAA must receive comments by February 3, 2020.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to ATR-GIE Avions de Transport R[eacute]gional
Model ATR42-500 airplanes, certificated in any category, as
identified in European Union Aviation Safety Agency (EASA) AD 2019-
0262, dated October 22, 2019 (``EASA AD 2019-0262'').

(d) Subject

    Air Transport Association (ATA) of America Code 27, Flight
controls.

(e) Reason

    This AD was prompted by a report of interference between bonding
braid screws and pitch tab control rods on the ATR final assembly
line. The FAA is issuing this AD to address interference between
bonding braid screws and pitch tab control rods, which

could lead to failure of the rods and tab disconnection, possibly
resulting in reduced control of the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Requirements

    Except as specified in paragraph (h) of this AD: Comply with all
required actions and compliance times specified in, and in
accordance with, EASA AD 2019-0262.

(h) Exceptions to EASA AD 2019-0262

    (1) Where EASA AD 2019-0262 refers to its effective date, this
AD requires using the effective date of this AD.
    (2) The ``Remarks'' section of EASA AD 2019-0262 does not apply
to this AD.

(i) No Reporting Requirement

    Although the service information referenced in EASA AD 2019-0262
specifies to submit certain information to the manufacturer, this AD
does not include that requirement.

 (j) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Section, Transport Standards Branch, FAA, has the
authority to approve AMOCs for this AD, if requested using the
procedures found in 14 CFR 39.19. In accordance with 14 CFR 39.19,
send your request to your principal inspector or local Flight
Standards District Office, as appropriate. If sending information
directly to the International Section, send it to the attention of
the person identified in paragraph (k)(2) of this AD. Information
exception occurred on : 2019-27318.htm
exception occurred on : 2019-27318.htm
may be emailed to: 9-ANM-116-AMOC-RE[email protected]. Before using any
approved AMOC, notify your appropriate principal inspector, or
lacking a principal inspector, the manager of the local flight
standards district office/certificate holding district office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, International
Section, Transport Standards Branch, FAA; or EASA; or ATR-GIE Avions
de Transport R[eacute]gional's EASA Design Organization Approval
(DOA). If approved by the DOA, the approval must include the DOA-
authorized signature.

(k) Related Information

    (1) For information about EASA AD 2019-0262, contact the EASA,
Konrad-Adenauer-Ufer 3, 50668 Cologne, Germany; telephone +49 221
89990 6017; email<EMAIL_ADDRESS>internet www.easa.europa.eu.
You may find this EASA AD on the EASA website at https://ad.easa.europa.eu. You may view this material at the FAA, Transport
Standards Branch, 2200 South 216th St., Des Moines, WA. For
information on the availability of this material at the FAA, call
206-231-3195. This material may be found in the AD docket on the
internet at https://www.regulations.gov by searching for and
locating Docket No. FAA-2019-0985.
    (2) For more information about this AD, contact Shahram
Daneshmandi, Aerospace Engineer, International Section, Transport
Standards Branch, FAA, 2200 South 216th St., Des Moines, WA 98198;
telephone and fax<PHONE_NUMBER>.

    Issued in Des Moines, Washington, on December 12, 2019.
Suzanne Masterson,
Acting Director, System Oversight Division, Aircraft Certification
Service.
[FR Doc. 2019-27318 Filed 12-18-19; 8:45 am]
 BILLING CODE 4910-13-P


[Federal Register Volume 84, Number 88 (Tuesday, May 7, 2019)]
[Notices]
[Pages 19918-19920]
[FR Doc No: 2019-09261]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-2535-009.
    Applicants: Mendota Hills, LLC.
    Description: Notice of Non-Material Change in Status of Mendota
Hills, LLC.
    Filed Date: 4/26/19.
    Accession Number: 20190426-5256.
    Comments Due: 5 p.m. ET 5/17/19.

    Docket Numbers: ER18-1775-002.
    Applicants: 64KT 8me LLC.
    Description: Notice of Non-Material Change In Status of 64KT 8me
LLC.
    Filed Date: 4/26/19.
    Accession Number: 20190426-5239.
    Comments Due: 5 p.m. ET 5/17/19.

    Docket Numbers: ER19-718-001.
    Applicants: Duke Energy Carolinas, LLC.
    Description: Compliance filing: DEC Compliance Filing Revised
Tariff Records per April 2, 2019 Order to be effective 1/1/2018.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5133.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1012-001.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Amendment: Response to Deficiency Letter Issued
3/29/19 re: Price Responsive Demand Update to be effective 4/9/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5134.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1691-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 1958 Ameren-
Mt. Carmel WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5006.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1692-000.
    Applicants: Duke Energy Progress, LLC.
    Description: Tariff Cancellation: DEP-Notice of Termination (RS
Nos. 174, 175, 176, 177, & 178) to be effective 6/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5012.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1693-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original WMPA, SA No. 5374;
Queue No. AE1-027 to be effective 3/29/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5052.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1694-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Revisions to the OATT and OA
re: Definition of On-Site Generator to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5053.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1696-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: Attachment O Section III.5
Revisions to be effective 6/28/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5087.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1697-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Cancellation: Notice of Cancellation of WMPA/
ISA No. 5041; Queue No. AC2-089 to be effective 5/21/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5090.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1698-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original WMPA, SA No. 5375;
Queue No. AE1-028 to be effective 3/29/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5123.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1699-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: 1st Quarter 2019 Revisions
to OA, Schedule 12 and RAA, Schedule 17 to be effective 3/31/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5153.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1700-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 2003 Ameren-
Newton WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5154.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1701-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 2001 Ameren-
PPI WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5155.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1702-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original WMPA, SA No. 5376;
Queue No. AE1-098 to be effective 3/29/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5158.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1703-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 2006 Ameren-
SWEC WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5162.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1704-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 2010 Ameren-
SIPC WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5169.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1705-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 1970 Ameren-
Wabash Valley WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5173.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1706-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 1975 Ameren-
Norris WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5186.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1707-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2019-04-29_SA 3066 Ameren-
RECC WDS Agreement to be effective 7/1/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5187.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1708-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original WMPA, SA No. 5377;
Queue No. AE1-099 to be effective 3/29/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5200.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1709-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISA, SA No.
4511; Queue No. AB1-127 to be effective 7/13/2016.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5201.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1710-000.
    Applicants: AEP Ohio Transmission Company, Inc., Ohio Power
Company, PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: AEP Ohio submits an ILDSA,
Service Agreement No. 1675 and City of Jackson FA to be effective 4/29/
2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5239.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1711-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Amendment to ISAs, SA Nos.
2836 & 2837 re: FES to Vermillion Power (consent) to be effective 6/1/
2011.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5247.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1712-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Original ISA, SA No. 5360;
Queue No. Z1-116 to be effective 3/28/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5259.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1713-000.
    Applicants: Capitol District Energy Center Cogeneration Associates.
    Description: Sec.  205(d) Rate Filing: Notification of Change in
Status and Category Change to be effective 4/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5262.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1714-000.
    Applicants: Pawtucket Power Associates Limited Partnership.
    Description: Sec.  205(d) Rate Filing: Notification of Change in
Status and Category Change to be effective 4/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5268.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1715-000.
    Applicants: Pittsfield Generating Company, L.P.
    Description: Sec.  205(d) Rate Filing: Notification of Change in
Status and Category Change to be effective 4/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5277.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1716-000.
    Applicants: Morgan Stanley Energy Structuring, L.L.C
    Description: Sec.  205(d) Rate Filing: Name change filing Normal
2019 to be effective 4/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5282.
    Comments Due: 5 p.m. ET 5/20/19.

    Docket Numbers: ER19-1717-000.
    Applicants: Forked River Power LLC.
    Description: Sec.  205(d) Rate Filing: Notification of Change in
Status and Category Change to be effective 4/30/2019.
    Filed Date: 4/29/19.
    Accession Number: 20190429-5285.
    Comments Due: 5 p.m. ET 5/20/19.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES19-26-000.
    Applicants: MidAmerican Energy Company.
    Description: Application under Section 204 of the Federal Power Act
for Authorization to Issue Securities of MidAmerican Energy Company.
    Filed Date: 4/26/19.
    Accession Number: 20190426-5245.
    Comments Due: 5 p.m. ET 5/17/19.

    Take notice that the Commission received the following qualifying
facility filings:

    Docket Numbers: QF19-1121-000.
    Applicants: Freeport LNG Development, L.P.
    Description: Form 556 of Freeport LNG Development, L.P.
    Filed Date: 4/25/19.
    Accession Number: 20190425-5249.
    Comments Due: None-Applicable.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: April 29, 2019.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2019-09261 Filed 5-6-19; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: May 4, 2010 (Volume 75, Number 85)]
[Rules and Regulations]
[Page 23581-23582]
[DOCID:fr04my10-10]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2009-1153; Airspace Docket No. 09-ACE-13]

Amendment of Class E Airspace; Emmetsburg, IA

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This action amends Class E airspace for Emmetsburg, IA, adding
additional controlled airspace to accommodate Area Navigation (RNAV)
Standard Instrument Approach Procedures (SIAPs) at Emmetsburg Municipal
Airport, Emmetsburg, IA. The FAA is taking this action to enhance the
safety and management of Instrument Flight Rule (IFR) operations at the
airport.

DATES: Effective date 0901 UTC, July 29, 2010. The Director of the
Federal Register approves this incorporation by reference action under
1 CFR part 51, subject to the annual revision of FAA Order 7400.9 and
publication of conforming amendments.

FOR FURTHER INFORMATION CONTACT: Scott Enander, Central Service Center,
Operations Support Group, Federal Aviation Administration, Southwest
Region, 2601 Meacham Blvd., Fort Worth, TX 76137; telephone (817) 321-
7716.

SUPPLEMENTARY INFORMATION:

History

    On February 10, 2010, the FAA published in the Federal Register a
notice of proposed rulemaking to amend Class E airspace for Emmetsburg,
IA, reconfiguring controlled airspace at Emmetsburg Municipal Airport
(75 FR 6592) Docket No. FAA-2009-1153. Interested parties were invited
to participate in this rulemaking effort by submitting written comments
on the proposal to the FAA. No comments were received. Class E airspace
designations are published in paragraph 6005 of FAA Order 7400.9T
signed August 27, 2009, and effective September 15, 2009, which is
incorporated by reference in 14 CFR 71.1. The Class E airspace
designations listed in this document will be published subsequently in
the Order.

The Rule

    This action amends Title 14 Code of Federal Regulations (14 CFR)
Part 71 by amending Class E airspace for the Emmetsburg, IA area,
adding additional controlled airspace extending upward from 700 feet
above the surface to accommodate SIAPs at Emmetsburg Municipal Airport.
This action is necessary for the safety and management of IFR
operations at the airport.
    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
Therefore, this regulation: (1) Is not a ``significant regulatory
action'' under Executive Order 12866; (2) is not a ``significant rule''
under DOT Regulatory Policies and Procedures (44 FR 11034; February 26,
1979); and (3) does not warrant preparation of a regulatory evaluation
as the anticipated impact is so minimal. Since this is a routine matter
that will only affect air traffic procedures and air navigation, it is
certified that this rule, when promulgated, will not have a significant
economic impact on a substantial number of small entities under the
criteria of the Regulatory Flexibility Act. The FAA's authority to
issue rules regarding aviation safety is found in Title 49 of the U.S.
Code. Subtitle 1, section 106, describes the authority of the FAA
Administrator. Subtitle VII, Aviation Programs, describes in more
detail the scope of the agency's authority. This rulemaking is
promulgated under the authority described in subtitle VII, part A,
subpart I, section 40103. Under that section, the FAA is charged with
prescribing regulations to assign the use of airspace necessary to
ensure the safety of aircraft and the efficient use of airspace. This
regulation is within the scope of that authority as it amends
controlled airspace at Emmetsburg Municipal Airport, Emmetsburg, IA.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

Adoption of the Amendment

0
In consideration of the foregoing, the Federal Aviation Administration
amends 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for 14 CFR part 71 continues to read as
follows:

    Authority: 49 U.S.C. 106(g), 40103, 40113, 40120; E.O. 10854, 24
FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR Part 71.1 of the Federal
Aviation Administration Order 7400.9T, Airspace Designations and
Reporting Points, signed August 27, 2009, and effective September 15,
2009, is amended as follows:
* * * * *

Paragraph 6005 Class E airspace areas extending upward from 700
feet or more above the surface.

* * * * *

ACE IA E5 Emmetsburg, IA [Amended]

Emmetsburg Municipal Airport, IA
    (Lat. 43[deg]06'07'' N., long. 94[deg]42'17'' W.)
Emmetsburg NDB
    (Lat. 43[deg]06'04'' N., long. 94[deg]42''26'' W.)

    That airspace extending upward from 700 feet above the surface
within a 6.5-mile radius of Emmetsburg Municipal Airport and within
2.6 miles each side of the 128[deg] bearing from the Emmetsburg NDB
extending from the 6.5-mile radius to 7.4 miles southeast of the
airport, and within 3.8 miles each side of the 316[deg] bearing from
the airport extending from the 6.5-mile radius to 10.3 miles
northwest of the airport.

    Issued in Fort Worth, Texas, on April 23, 2010.
Anthony D. Roetzel,
Manager, Operations Support Group, ATO Central Service Center.
[FR Doc. 2010-10325 Filed 5-3-10; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 79, Number 113 (Thursday, June 12, 2014)]
[Notices]
[Page 33761]
[FR Doc No: 2014-13638]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-E-0157]

Determination of Regulatory Review Period for Purposes of Patent
Extension; Arcapta Neohaler

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) has determined the
regulatory review period for Arcapta Neohaler and is publishing this
notice of that determination as required by law. FDA has made the
determination because of the submission of an application to the
Director of the U.S. Patent and Trademark Office (USPTO), Department of
Commerce, for the extension of a patent which claims that human drug
product.

ADDRESSES: Submit electronic comments to http://www.regulations.gov.
Submit written petitions (two copies are required) and written comments
to the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Submit petitions electronically to http://www.regulations.gov at Docket
No. FDA-2013-S-0610.

FOR FURTHER INFORMATION CONTACT: Beverly Friedman, Office of
Management, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 51, Rm. 6257, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The Drug Price Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98-417) and the Generic Animal Drug
and Patent Term Restoration Act (Pub. L. 100-670) generally provide
that a patent may be extended for a period of up to 5 years so long as
the patented item (human drug product, animal drug product, medical
device, food additive, or color additive) was subject to regulatory
review by FDA before the item was marketed. Under these acts, a
product's regulatory review period forms the basis for determining the
amount of extension an applicant may receive.
    A regulatory review period consists of two periods of time: A
testing phase and an approval phase. For human drug products, the
testing phase begins when the exemption to permit the clinical
investigations of the drug becomes effective and runs until the
approval phase begins. The approval phase starts with the initial
submission of an application to market the human drug product and
continues until FDA grants permission to market the drug product.
Although only a portion of a regulatory review period may count toward
the actual amount of extension that the Director of USPTO may award
(for example, half the testing phase must be subtracted as well as any
time that may have occurred before the patent was issued), FDA's
determination of the length of a regulatory review period for a human
drug product will include all of the testing phase and approval phase
as specified in 35 U.S.C. 156(g)(1)(B).
    FDA has approved for marketing the human drug product Arcapta
Neohaler (indacaterol maleate). Arcapta Neohaler is indicated for long
term, once-daily maintenance bronchodilator treatment of airflow
obstruction in patients with chronic obstructive pulmonary disease,
including chronic bronchitis and/or emphysema. Subsequent to this
approval, the Patent and Trademark Office received a patent term
restoration application for Arcapta Neohaler (U.S. Patent No.
6,878,721) from Novartis AG, and USPTO requested FDA's assistance in
determining this patent's eligibility for patent term restoration. In a
letter dated July 9, 2012, FDA advised USPTO that this human drug
product had undergone a regulatory review period and that the approval
of Arcapta Neohaler represented the first permitted commercial
marketing or use of the product. Thereafter, USPTO requested that FDA
determine the product's regulatory review period.
    FDA has determined that the applicable regulatory review period for
Arcapta Neohaler is 3,097 days. Of this time, 2,171 days occurred
during the testing phase of the regulatory review period, while 926
days occurred during the approval phase. These periods of time were
derived from the following dates:
    1. The date an exemption under section 505(i) of the Federal Food,
Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 355(i)) became
effective: January 9, 2003. FDA has verified the applicant's claim that
the date the investigational new drug application became effective was
on January 9, 2003.
    2. The date the application was initially submitted with respect to
the human drug product under section 505(b) of the FD&C Act: December
18, 2008. The applicant claims December 19, 2008, as the date the new
drug application (NDA) for Arcapta Neohaler (NDA 22-383) was initially
submitted. However, FDA records indicate that NDA 22-383 was submitted
on December 18, 2008.
    3. The date the application was approved: July 1, 2011. FDA has
verified the applicant's claim that NDA 22-383 was approved on July 1,
2011.
    This determination of the regulatory review period establishes the
maximum potential length of a patent extension. However, USPTO applies
several statutory limitations in its calculations of the actual period
for patent extension. In its application for patent extension, this
applicant seeks 1,597 days of patent term extension.
    Anyone with knowledge that any of the dates as published are
incorrect may submit to the Division of Dockets Management (see
ADDRESSES) either electronic or written comments and ask for a
redetermination by August 11, 2014. Furthermore, any interested person
may petition FDA for a determination regarding whether the applicant
for extension acted with due diligence during the regulatory review
period by December 9, 2014. To meet its burden, the petition must
contain sufficient facts to merit an FDA investigation. (See H. Rept.
857, part 1, 98th Cong., 2d sess., pp. 41-42, 1984.) Petitions should
be in the format specified in 21 CFR 10.30.
    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) electronic or written comments and written or
electronic petitions. It is only necessary to send one set of comments.
Identify comments with the docket number found in brackets in the
heading of this document. If you submit a written petition, two copies
are required. A petition submitted electronically must be submitted to
http://www.regulations.gov, Docket No. FDA-2013-S-0610. Comments and
petitions that have not been made publicly available on http://www.regulations.gov may be viewed in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: June 5, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-13638 Filed 6-11-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Page 5415]
[FR Doc No: 2020-01689]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP20-10-000]

Rover Pipeline LLC; Notice of Schedule for Environmental Review
of the Wick Meter and Regulator Station Project

    On November 1, 2019, Rover Pipeline LLC (Rover) filed an
application in Docket No. CP20-10-000 requesting a Certificate of
Public Convenience and Necessity pursuant to Section 7(c) of the
Natural Gas Act to construct, own, and operate a new meter station. The
Wick Meter and Regulator Station Project (Project) would allow for the
delivery of natural gas supplies from gathering facilities, under
development by Eureka Midstream, LLC, for transportation on the Rover
pipeline system, and it would be located along Rover's Sherwood Lateral
Pipeline in Tyler County, West Virginia.
    On November 19, 2019, the Federal Energy Regulatory Commission
(Commission or FERC) issued its Notice of Application for the Project.
Among other things, that notice alerted agencies issuing federal
authorizations of the requirement to complete all necessary reviews and
to reach a final decision on a request for a federal authorization
within 90 days of the date of issuance of the Commission staff's
Environmental Assessment (EA) for the Project. This instant notice
identifies the FERC staff's planned schedule for the completion of the
EA for the Project.

Schedule for Environmental Review

    Issuance of EA: March 13, 2020.
    90-day Federal Authorization Decision Deadline: June 11, 2020.
    If a schedule change becomes necessary, additional notice will be
provided so that the relevant agencies are kept informed of the
Project's progress.

Project Description

    The Wick Meter and Regulator Station Project would consist of an
ultrasonic meter skid and other ancillary facilities in Tyler County,
West Virginia. The ancillary facilities would include piping and
valves, electronic flow measurement devices, flow conditioners,
instrumentation, telemetry, gas analysis devices, gas quality
monitoring devices, flow control valves, condensate storage tank, and
other related equipment. Rover would use about 2.1 acres of land to
construct the station, of which 0.9 acre would be fenced and maintained
for operation of the station.

Background

    On January 21, 2020, the Commission issued a Notice of Intent to
Prepare an Environmental Assessment for the Proposed Wick Meter and
Regulator Station Project and Request for Comments on Environmental
Issues (NOI). The NOI was sent to affected landowners; federal, state,
and local government agencies; elected officials; environmental and
public interest groups; Native American tribes; other interested
parties. To date, no comments have been received in response to the
NOI. All substantive comments will be addressed in the EA.

Additional Information

    In order to receive notification of the issuance of the EA and to
keep track of all formal issuances and submittals in specific dockets,
the Commission offers a free service called eSubscription. This can
reduce the amount of time you spend researching proceedings by
automatically providing you with notification of these filings,
document summaries, and direct links to the documents. Go to
www.ferc.gov/docs-filing/esubscription.asp.
    Additional information about the Project is available from the
Commission's Office of External Affairs at (866) 208-FERC or on the
FERC website (www.ferc.gov). Using the eLibrary link, select General
Search from the eLibrary menu, enter the selected date range and Docket
Number excluding the last three digits (i.e., CP20-10), and follow the
instructions. For assistance with access to eLibrary, the helpline can
be reached at<PHONE_NUMBER>, TTY<PHONE_NUMBER>, or at
<EMAIL_ADDRESS>The eLibrary link on the FERC website also
provides access to the texts of formal documents issued by the
Commission, such as orders, notices, and rule makings.

    Dated: January 24, 2020.
Kimberly D. Bose,
Secretary.
[FR Doc. 2020-01689 Filed 1-29-20; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 131 (Tuesday, July 9, 2019)]
[Notices]
[Page 32805]
[FR Doc No: 2019-14525]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release Nos. 33-10658; 34-86289; File No. 265-28]

Investor Advisory Committee Meeting

AGENCY: Securities and Exchange Commission.

ACTION: Notice of meeting of Securities and Exchange Commission Dodd-
Frank Investor Advisory Committee.

-----------------------------------------------------------------------

SUMMARY: The Securities and Exchange Commission Investor Advisory
Committee, established pursuant to Section 911 of the Dodd-Frank Wall
Street Reform and Consumer Protection Act of 2010, is providing notice
that it will hold a public meeting. The public is invited to submit
written statements to the Committee.

DATES: The meeting will be held on Thursday, July 25, 2019 from 9 a.m.
until 3 p.m. (ET). Written statements should be received on or before
July 25, 2019.

ADDRESSES: The meeting will be held in Multi-Purpose Room LL-006 at the
Commission's headquarters, 100 F Street NE, Washington, DC 20549. The
meeting will be webcast on the Commission's website at www.sec.gov.
Written statements may be submitted by any of the following methods:

Electronic Statements

    [ssquf] Use the Commission's internet submission form (http://www.sec.gov/rules/other.shtml); or
    [ssquf] Send an email message to<EMAIL_ADDRESS>Please
include File No. 265-28 on the subject line; or

Paper Statements

    [ssquf] Send paper statements to Vanessa A. Countryman, Secretary,
Securities and Exchange Commission, 100 F Street NE, Washington, DC
20549-1090.

    All submissions should refer to File No. 265-28. This file number
should be included on the subject line if email is used. To help us
process and review your statement more efficiently, please use only one
method.
    Statements also will be available for website viewing and printing
in the Commission's Public Reference Room, 100 F Street NE, Room 1503,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. All statements received will be posted without change.
Persons submitting comments are cautioned that we do not redact or edit
personal identifying information from comment submissions. You should
submit only information that you wish to make available publicly.

FOR FURTHER INFORMATION CONTACT: Marc Oorloff Sharma, Chief Counsel,
Office of the Investor Advocate, at<PHONE_NUMBER>, Securities and
Exchange Commission, 100 F Street NE, Washington, DC 20549.

SUPPLEMENTARY INFORMATION: The meeting will be open to the public,
except during that portion of the meeting reserved for an
administrative work session during lunch. Persons needing special
accommodations to take part because of a disability should notify the
contact person listed in the section above entitled FOR FURTHER
INFORMATION CONTACT.
    The agenda for the meeting includes: Welcome remarks; a discussion
regarding regulation in areas with limited completion, a discussion
regarding trends in investment research (which may include a
recommendation from the Market Structure subcommittee); a discussion
regarding the proxy process (which may include a recommendation from
the Investor as Owner subcommittee); a presentation on the work of the
Office of the Advocate for Small Business Capital Formation; a
presentation on the work of the Office of Minority and Women Inclusion;
subcommittee reports; and a nonpublic administrative work session
during lunch.

    Dated: July 3, 2019.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2019-14525 Filed 7-8-19; 8:45 am]
 BILLING CODE 8011-01-P